XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Taxes  
Schedule of income (loss) before income taxes

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 31,

 

    

2020

    

2019

U.S.

 

$

(28,699)

 

$

(32,875)

Foreign

 

 

1,183

 

 

(28)

Loss before income taxes

 

$

(27,516)

 

$

(32,903)

 

Schedule of Company's current and deferred expense for income tax

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 31, 

 

    

2020

    

2019

Current expense (benefit):

 

 

 

 

 

 

Federal

 

$

 —

 

$

 —

State

 

 

 —

 

 

 —

Foreign

 

 

40

 

 

 —

Total current expense (benefit):

 

$

40

 

$

 —

Deferred expense (benefit):

 

 

 

 

 

 

Federal

 

$

 —

 

$

 —

State

 

 

 —

 

 

 —

Foreign

 

 

(42)

 

 

(3)

Total deferred expense (benefit):

 

$

(42)

 

$

(3)

Total income tax expense (benefit):

 

$

(2)

 

$

(3)

 

Schedule of reconciliation of the Company's statutory income tax rate to the Company's effective income tax rate

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 31, 

 

 

    

2020

    

2019

 

Income at US Statutory Rate

 

21.00

%  

21.00

%

State Taxes, net of Federal benefit

 

6.97

%  

6.79

%

Permanent Differences

 

(1.09)

%  

(0.33)

%

Tax Credits

 

5.98

%  

3.30

%

Tax Law Change

 

(0.04)

%  

0.00

%

Foreign Rate Differential

 

(0.46)

%  

0.07

%

Israel DTA write-off

 

(70.15)

%  

0.00

%  

Valuation Allowance

 

36.56

%  

(40.18)

%

Other

 

1.23

%  

9.35

%

 

 

0.00

%  

0.00

%

 

Schedule of significant components of the Company's deferred tax assets

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 31, 

 

    

2020

    

2019

Accrued expenses

 

 

455

 

 

277

License Fees

 

 

1,168

 

 

1,332

Stock Options

 

 

3,759

 

 

2,584

Other

 

 

228

 

 

115

State net operating loss carryforwards

 

 

8,959

 

 

7,431

State research tax credits

 

 

625

 

 

510

Federal net operating loss carryforwards

 

 

33,711

 

 

47,845

Federal research tax credits

 

 

4,943

 

 

3,770

Total deferred tax assets

 

 

53,848

 

 

63,864

Valuation allowance

 

 

(53,669)

 

 

(63,737)

Net deferred tax asset (liability)

 

 

179

 

 

127